These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7558893)

  • 21. Onset and distribution of factor XIII-containing cells in the mesenchyme of chorionic villi during early phase of human placentation.
    Kappelmayer J; Bacskó G; Kelemen E; Adány R
    Placenta; 1994 Sep; 15(6):613-23. PubMed ID: 7824447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible role for cellular FXIII in monocyte-derived dendritic cell motility.
    Jayo A; Conde I; Lastres P; Jiménez-Yuste V; González-Manchón C
    Eur J Cell Biol; 2009 Aug; 88(8):423-31. PubMed ID: 19477035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor XIII: a marker of mono- and megakaryocytopoiesis.
    Adány R; Kiss A; Muszbek L
    Br J Haematol; 1987 Oct; 67(2):167-72. PubMed ID: 3314976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factor XIII of blood coagulation as a nuclear crosslinking enzyme.
    Adány R; Bárdos H; Antal M; Módis L; Sárváry A; Szücs S; Balogh I
    Thromb Haemost; 2001 May; 85(5):845-51. PubMed ID: 11372678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of factor XIII-A is a valuable tool for distinguishing dendritic cells and tissue macrophages in granuloma annulare and necrobiosis lipoidica.
    Töröcsik D; Bárdos H; Hatalyák Z; Dezső B; Losonczy G; Paragh L; Péter Z; Balázs M; Remenyik E; Adány R
    J Eur Acad Dermatol Venereol; 2014 Aug; 28(8):1087-96. PubMed ID: 24237365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The difference between platelet and plasma FXIII used to study the mechanism of platelet microvesicle formation.
    Holme PA; Brosstad F; Solum NO
    Thromb Haemost; 1993 Oct; 70(4):681-6. PubMed ID: 8115996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depletion of plasma factor XIII prevents disseminated intravascular coagulation-induced organ damage.
    Lee SY; Chang SK; Lee IH; Kim YM; Chung SI
    Thromb Haemost; 2001 Mar; 85(3):464-9. PubMed ID: 11307816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanisms of mutations in factor XIII A-subunit deficiency: in vitro expression in COS-cells demonstrates intracellular degradation of the mutant proteins.
    Mikkola H; Muszbek L; Haramura G; Hämäläinen E; Jalanko A; Palotie A
    Thromb Haemost; 1997 Jun; 77(6):1068-72. PubMed ID: 9241733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulated monocytes release factor XIII subunit A and fibronectin in vitro.
    Kłoczko J; Giedrojć J; Radziwon P; Galar M; Bielawiec M
    Rocz Akad Med Bialymst; 1995; 40(2):408-13. PubMed ID: 8834625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel proangiogenic effect of factor XIII associated with suppression of thrombospondin 1 expression.
    Dardik R; Solomon A; Loscalzo J; Eskaraev R; Bialik A; Goldberg I; Schiby G; Inbal A
    Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1472-7. PubMed ID: 12805075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factor XIII subunit A as an intracellular transglutaminase.
    Adány R; Bárdos H
    Cell Mol Life Sci; 2003 Jun; 60(6):1049-60. PubMed ID: 12861374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of coagulation factor XIII-A with Golgi proteins within monocyte-macrophages: implications for subcellular trafficking and secretion.
    Cordell PA; Kile BT; Standeven KF; Josefsson EC; Pease RJ; Grant PJ
    Blood; 2010 Apr; 115(13):2674-81. PubMed ID: 20086247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A simple, quick one-step ELISA assay for the determination of complex plasma factor XIII (A2B2).
    Katona E; Haramura G; Kárpáti L; Fachet J; Muszbek L
    Thromb Haemost; 2000 Feb; 83(2):268-73. PubMed ID: 10739385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracellular factor XIII crosslinks platelet cytoskeletal elements upon platelet activation.
    Serrano K; Devine DV
    Thromb Haemost; 2002 Aug; 88(2):315-20. PubMed ID: 12195706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sushi domains in the B subunit of factor XIII responsible for oligomer assembly.
    Souri M; Kaetsu H; Ichinose A
    Biochemistry; 2008 Aug; 47(33):8656-64. PubMed ID: 18652485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and pharmacokinetics of recombinant factor XIII in healthy volunteers: a randomized, placebo-controlled, double-blind, multi-dose study.
    Visich JE; Zuckerman LA; Butine MD; Gunewardena KA; Wild R; Morton KM; Reynolds TC
    Thromb Haemost; 2005 Oct; 94(4):802-7. PubMed ID: 16270634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombelastographic method to quantify the contribution of factor XIII to coagulation kinetics.
    Nielsen VG; Kirklin JK; Hoogendoorn H; Ellis TC; Holman WL
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):145-50. PubMed ID: 17287631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced levels of coagulation factor XIII in patients with advanced tumor disease.
    Born P; Lippl F; Ulm K; Gerein P; Lersch C; Eckel F; Fischer G; Sandschin W; Dlaska U; Classen M
    Hepatogastroenterology; 2000; 47(31):194-8. PubMed ID: 10690608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.